Industry Trends

Clinical and preclinical are distinctions that could guide patient treatment, public health and medical policy going forward, according to study commission.

Data from the recent AMGA 2024 Medical Group Operations and Finance Survey reveal medical groups continue to face challenges related to providing quality, cost-effective care in a constantly evolving health care environment.

A policy scenario to lower nicotine in tobacco products was published during the first Trump administration. FDA may be poised to bring it back for more consideration.

New perspective calls for regulatory reforms to address the rising trend of physician strikes in the U.S. based on international examples.

Financial sustainability of some hospitals comes into question

Two companies highlighted in bipartisan review of ‘detrimental effects of PE ownership on hospitals and their patients.’

Where will you go to meet fellow professionals this year?

Recommendations and resources from U.S. Surgeon General Vivek Murthy, MD, MBA.

Less clear is whether social drivers of health screenings are improving patient outcomes, according to a new study.

Systematic review examines effects of corporatization through mergers and acquisitions since 2000.

Physicians are in high demand — here’s how to find your new role

AANP offers five critical health care trends for next year.

Zocdoc’s 2024 “What Patients Want” report highlights year-over-year trends in patient preferences, behaviors and sentiments.

As health care sector readies for change in the White House, Big Cities Health Coalition outlines policy priorities for next year.

McKinsey & Company analyzed recent trends to explain how the health care industry can weather ongoing challenges, and capitalize on emerging opportunities, in a new report.

A new Medscape and HIMSS report found that AI in health care settings is primarily used for administrative tasks, with clinical applications still in the early stages of adoption.

As a result of shifts in the primary care landscape, Bain & Company has made important adjustments to their 2030 market share forecast from two years ago.

The regulatory battle over compounded semaglutide and health effects on the heart are among latest developments involving GLP-1 RA drugs.

Robert Kushner, MD, an expert in overweight, obesity, nutrition, diet and exercise, discusses the effects of the new antiobesity medications.

Independent oncologists are important for patient health and cost-effective care

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

Pradeep Kumar Jain, senior director of health care at Tredence, outlined five significant predictions for 2025.

Employers face tough decisions on health care coverage as costs continue to rise.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

Mental health treatment access is low while cost is high. Here’s what to know about digital solutions.